HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysisSantam Chakraborty, Debdeep Dey, Sanjoy Chatterjee et al.|Radiotherapy and Oncology|2022Cited by 42
Resource requirements and reduction in cardiac mortality from deep inspiration breath hold (DIBH) radiation therapy for left sided breast cancer patients: A prospective service development analysisSanjoy Chatterjee, Rosina Ahmed, Santam Chakraborty et al.|Practical Radiation Oncology|2018Cited by 32
Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trialSanjoy Chatterjee, Santam Chakraborty, Selvamani Backianathan et al.|Trials|2020Cited by 29
Alleviating Morbidity From Locally Advanced Breast Cancer Using a Practical and Short Radiation Therapy Regimen: Results of the HYPORT Palliative StudiesSanjoy Chatterjee, Soumendranath Ray, Santam Chakrabarty et al.|International Journal of Radiation Oncology*Biology*Physics|2023Cited by 22
Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT projectShelley Potter, Stuart McIntosh, Fiorita Poulakaki et al.|BMJ Open|2024Cited by 12